Skip to content

Clinical trials

Phase 3 Respiratory Syncytial Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Phase: Phase 3 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20153
20191
20202
20217
20227
20234
20249
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting5
Active, not recruiting4
Terminated4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline21
AstraZeneca2
Pfizer2
AbbVie (prior sponsor, Abbott)1
Bavarian Nordic1
Kexing Biopharm Co., Ltd.1
MedImmune LLC1
Merck Sharp & Dohme LLC1
National Institute of Allergy and Infectious Diseases (NIAID)1
Novavax1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections40
Infections1
Obstetric Labor, Premature1
Tetanus1

Trials

Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.